share_log

JP Morgan Maintains Overweight on CVS Health, Lowers Price Target to $86

Benzinga ·  May 30 14:16

JP Morgan analyst Lisa Gill maintains CVS Health (NYSE:CVS) with a Overweight and lowers the price target from $101 to $86.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment